CADTH conducted an ultra-rapid response report to evaluate the clinical utility of pulse oximetry monitoring (including portable pulse oximetry devices) for patients at risk of hypoxia (oxygen deficiency) due to COVID-19. CADTH’s review also searched for any evidence-based guidelines. No evidence specific to COVID-19 was identified; however, four non-randomized studies of patients at risk of hypoxia for other reasons were included in this report. No evidence-based guidelines were identified.
Link to Report
Provide Feedback
Was this site helpful?
If you couldn’t find what you are looking for, please submit a request.